BaldessariniRJ. Drugs and the treatment of psychiatric disorders. In: Goodman & Gilman's: The pharmacological basis of therapeutics. New York: McGraw-Hill; 1996. p 399–459.
2.
NemeroffCBDeVaneC LindsayPollockBG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry1996;153:311–20.
3.
PreskornSH. Reducing the risk of drug-drug interactions: A goal of rational drug development. J Clin Psychiatry1996;57(1 Suppl):3–6.
4.
KetterTAFlockhartDAPostRMDenicoffKPazzagliaPJMarangellLB, and others. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol1995; 15:387–98.
5.
CoulterDMPillansPI. Fluoxetine and extrapyramidal side effects. Am J Psychiatry1995;152:122–5.
6.
KapurSRemingtonG.Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry1996;153:466–76.